• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Inhibition of Aurora A promotes chemosensitivity via inducing cell cycle arrest and apoptosis in cervical cancer cells.抑制极光激酶A通过诱导宫颈癌细胞的细胞周期阻滞和凋亡来促进化学敏感性。
Am J Cancer Res. 2015 Feb 15;5(3):1133-45. eCollection 2015.
2
Aurora-A, a negative prognostic marker, increases migration and decreases radiosensitivity in cancer cells.Aurora-A是一种负面预后标志物,它会增加癌细胞的迁移能力并降低其放射敏感性。
Cancer Res. 2007 Nov 1;67(21):10436-44. doi: 10.1158/0008-5472.CAN-07-1379.
3
Constitutive phosphorylation of aurora-a on ser51 induces its stabilization and consequent overexpression in cancer.极光激酶A在丝氨酸51位点的组成性磷酸化会诱导其稳定性增加,并导致其在癌症中过度表达。
PLoS One. 2007 Sep 26;2(9):e944. doi: 10.1371/journal.pone.0000944.
4
A novel arylbenzofuran induces cervical cancer cell apoptosis and G1/S arrest through ERK-mediated Cdk2/cyclin-A signaling pathway.一种新型芳基苯并呋喃通过ERK介导的Cdk2/细胞周期蛋白A信号通路诱导宫颈癌细胞凋亡和G1/S期阻滞。
Oncotarget. 2016 Jul 5;7(27):41843-41856. doi: 10.18632/oncotarget.9731.
5
KCTD12 promotes tumorigenesis by facilitating CDC25B/CDK1/Aurora A-dependent G2/M transition.KCTD12通过促进依赖于CDC25B/CDK1/极光激酶A的G2/M期转换来促进肿瘤发生。
Oncogene. 2017 Nov 2;36(44):6177-6189. doi: 10.1038/onc.2017.287. Epub 2017 Sep 4.
6
Astragaloside IV enhances taxol chemosensitivity of breast cancer via caveolin-1-targeting oxidant damage.黄芪甲苷通过靶向窖蛋白-1的氧化损伤增强乳腺癌对紫杉醇的化疗敏感性。
J Cell Physiol. 2019 Apr;234(4):4277-4290. doi: 10.1002/jcp.27196. Epub 2018 Aug 26.
7
A novel CYR61-triggered 'CYR61-alphavbeta3 integrin loop' regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway.一种新型的由CYR61触发的“CYR61-αvβ3整合素环”通过激活ERK1/ERK2丝裂原活化蛋白激酶信号通路来调节乳腺癌细胞的存活和化学敏感性。
Oncogene. 2005 Jan 27;24(5):761-79. doi: 10.1038/sj.onc.1208238.
8
Aurora-A is a novel predictor of poor prognosis in patients with resected lung adenocarcinoma.极光激酶 A 是预测肺腺癌患者术后预后不良的一个新标志物。
Chin J Cancer Res. 2014 Apr;26(2):166-73. doi: 10.3978/j.issn.1000-9604.2014.04.08.
9
ZM447439, the Aurora kinase B inhibitor, suppresses the growth of cervical cancer SiHa cells and enhances the chemosensitivity to cisplatin.极光激酶B抑制剂ZM447439可抑制宫颈癌SiHa细胞的生长并增强对顺铂的化疗敏感性。
J Obstet Gynaecol Res. 2011 Jun;37(6):591-600. doi: 10.1111/j.1447-0756.2010.01414.x. Epub 2010 Dec 15.
10
Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cells.达努塞替布是一种强效的泛极光激酶和ABL激酶抑制剂,可诱导细胞周期停滞和程序性细胞死亡,并在人胃癌AGS和NCI-N78细胞中抑制涉及PI3K/Akt/mTOR介导的信号通路的上皮-间质转化。
Drug Des Devel Ther. 2015 Mar 2;9:1293-318. doi: 10.2147/DDDT.S74964. eCollection 2015.

引用本文的文献

1
Aurora kinase A (AURKA) promotes the progression and imatinib resistance of advanced gastrointestinal stromal tumors.极光激酶A(AURKA)促进晚期胃肠道间质瘤的进展和伊马替尼耐药。
Cancer Cell Int. 2021 Jul 31;21(1):407. doi: 10.1186/s12935-021-02111-7.
2
The impact of Aurora kinase A genetic polymorphisms on cervical cancer progression and clinicopathologic characteristics.极光激酶 A 基因多态性对宫颈癌进展及临床病理特征的影响。
Int J Med Sci. 2021 Apr 22;18(11):2457-2465. doi: 10.7150/ijms.58516. eCollection 2021.
3
Screening and Discovery of New Potential Biomarkers and Small Molecule Drugs for Cervical Cancer: A Bioinformatics Analysis.宫颈癌新型潜在生物标志物和小分子药物的筛选与发现:生物信息学分析。
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820980112. doi: 10.1177/1533033820980112.
4
The deubiquitinating enzyme UCHL1 promotes resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase.去泛素化酶UCHL1通过上调胸苷酸合成酶促进非小细胞肺癌对培美曲塞的耐药性。
Theranostics. 2020 May 15;10(13):6048-6060. doi: 10.7150/thno.42096. eCollection 2020.
5
Inhibition of Aurora Kinase A by Alisertib Reduces Cell Proliferation and Induces Apoptosis and Autophagy in HuH-6 Human Hepatoblastoma Cells.阿利西替尼抑制极光激酶A可减少HuH-6人肝母细胞瘤细胞的增殖并诱导其凋亡和自噬。
Onco Targets Ther. 2020 May 8;13:3953-3963. doi: 10.2147/OTT.S228656. eCollection 2020.
6
Identification of key genes and pathways of diagnosis and prognosis in cervical cancer by bioinformatics analysis.生物信息学分析鉴定宫颈癌诊断和预后的关键基因和通路。
Mol Genet Genomic Med. 2020 Jun;8(6):e1200. doi: 10.1002/mgg3.1200. Epub 2020 Mar 17.
7
Aurora-a confers radioresistance in human hepatocellular carcinoma by activating NF-κB signaling pathway.极光激酶 A 通过激活 NF-κB 信号通路赋予人肝癌细胞放射抗性。
BMC Cancer. 2019 Nov 8;19(1):1075. doi: 10.1186/s12885-019-6312-y.
8
Potential new biomarkers for squamous carcinoma of the uterine cervix.子宫颈鳞状细胞癌潜在的新型生物标志物。
ESMO Open. 2018 Jun 28;3(4):e000352. doi: 10.1136/esmoopen-2018-000352. eCollection 2018.
9
Pterostilbene modulates the suppression of multidrug resistance protein 1 and triggers autophagic and apoptotic mechanisms in cisplatin-resistant human oral cancer CAR cells via AKT signaling.紫檀芪通过AKT信号通路调节多药耐药蛋白1的抑制,并在顺铂耐药的人口腔癌CAR细胞中触发自噬和凋亡机制。
Int J Oncol. 2018 May;52(5):1504-1514. doi: 10.3892/ijo.2018.4298. Epub 2018 Mar 2.
10
Molecular targeting of the Aurora-A/SMAD5 oncogenic axis restores chemosensitivity in human breast cancer cells.极光激酶A/信号转导分子5致癌轴的分子靶向作用可恢复人乳腺癌细胞的化学敏感性。
Oncotarget. 2017 Sep 1;8(53):91803-91816. doi: 10.18632/oncotarget.20610. eCollection 2017 Oct 31.

本文引用的文献

1
Cervical cancer: prevention and treatment.宫颈癌:预防与治疗
Discov Med. 2012 Aug;14(75):125-31.
2
Developments in the systemic treatment of metastatic cervical cancer.转移性宫颈癌的系统治疗进展。
Cancer Treat Rev. 2013 Aug;39(5):430-43. doi: 10.1016/j.ctrv.2012.05.009. Epub 2012 Jun 22.
3
Adenovirus-mediated Aurora A shRNA driven by stathmin promoter suppressed tumor growth and enhanced paclitaxel chemotherapy sensitivity in human breast carcinoma cells.基质结合因子 stathmin 启动子驱动的腺病毒介导的 Aurora A shRNA 抑制人乳腺癌细胞的肿瘤生长并增强紫杉醇化疗敏感性。
Cancer Gene Ther. 2012 Apr;19(4):271-81. doi: 10.1038/cgt.2011.89. Epub 2012 Jan 27.
4
Worldwide burden of cervical cancer in 2008.2008 年全球宫颈癌负担。
Ann Oncol. 2011 Dec;22(12):2675-2686. doi: 10.1093/annonc/mdr015. Epub 2011 Apr 6.
5
Stanniocalcin 1 and ovarian tumorigenesis.斯钙素 1 与卵巢肿瘤发生。
J Natl Cancer Inst. 2010 Jun 2;102(11):812-27. doi: 10.1093/jnci/djq127. Epub 2010 May 18.
6
Aurora kinase A promotes ovarian tumorigenesis through dysregulation of the cell cycle and suppression of BRCA2.极光激酶 A 通过调控细胞周期和抑制 BRCA2 促进卵巢肿瘤发生。
Clin Cancer Res. 2010 Jun 15;16(12):3171-81. doi: 10.1158/1078-0432.CCR-09-3171. Epub 2010 Apr 27.
7
Biology of Aurora A kinase: implications in cancer manifestation and therapy.极光激酶 A 的生物学特性:在癌症发生和治疗中的意义。
Med Res Rev. 2011 Sep;31(5):757-93. doi: 10.1002/med.20203. Epub 2010 Mar 1.
8
Aurora kinase inhibitors--rising stars in cancer therapeutics?极光激酶抑制剂——癌症治疗领域的后起之秀?
Mol Cancer Ther. 2010 Feb;9(2):268-78. doi: 10.1158/1535-7163.MCT-09-0765. Epub 2010 Feb 2.
9
MK-5108, a highly selective Aurora-A kinase inhibitor, shows antitumor activity alone and in combination with docetaxel.MK-5108,一种高选择性的 Aurora-A 激酶抑制剂,单药及与多西他赛联合具有抗肿瘤活性。
Mol Cancer Ther. 2010 Jan;9(1):157-66. doi: 10.1158/1535-7163.MCT-09-0609. Epub 2010 Jan 6.
10
ERK and cell death: mechanisms of ERK-induced cell death--apoptosis, autophagy and senescence.ERK 和细胞死亡:ERK 诱导的细胞死亡——细胞凋亡、自噬和衰老的机制。
FEBS J. 2010 Jan;277(1):2-21. doi: 10.1111/j.1742-4658.2009.07366.x. Epub 2009 Oct 16.

抑制极光激酶A通过诱导宫颈癌细胞的细胞周期阻滞和凋亡来促进化学敏感性。

Inhibition of Aurora A promotes chemosensitivity via inducing cell cycle arrest and apoptosis in cervical cancer cells.

作者信息

Sun Jian-Ming, Yang Li-Na, Xu Han, Chang Bin, Wang Hua-Ying, Yang Gong

机构信息

Cancer Institute, Fudan University Shanghai Cancer Center Shanghai 200032, China ; Department of Gynecological Oncology, Fudan University Shanghai Cancer Center Shanghai 200032, China ; Department of Oncology, Shanghai Medical College, Fudan University Shanghai 200032, China ; Department of Obstetrics and Gynecology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine Shanghai 200062, China.

Cancer Institute, Fudan University Shanghai Cancer Center Shanghai 200032, China ; Department of Oncology, Shanghai Medical College, Fudan University Shanghai 200032, China.

出版信息

Am J Cancer Res. 2015 Feb 15;5(3):1133-45. eCollection 2015.

PMID:26045992
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4449441/
Abstract

Aurora kinase A (AurA) regulates genomic instability and tumorigenesis in multiple cancer types. Although some studies have reported that Aur A may predict cervical cancer outcomes, its precise function and molecular mechanism in cervical cancer pathogenesis remain unclear. In this study, by overexpression or silencing of Aur A in cervical cancer cell lines, we found that overexpression of Aur A promoted cell proliferation through G1/S cell cycle transition and anti-apoptosis, xenograft tumor growth and chemoresistance to Taxol. We further found that inhibition of Aur A with its specific inhibitor VX-680 enhanced the antitumor effect of Taxol via inducing apoptosis. Moreover, the clinical analysis from tissue samples demonstrated that Aur A was overexpressed, and the expression of Aur A and pERK1/2 was negatively correlated in cervical cancer tissues. The above results may provide some potential insights in treatment of cervical cancer in clinic.

摘要

极光激酶A(AurA)在多种癌症类型中调节基因组不稳定性和肿瘤发生。尽管一些研究报道AurA可能预测宫颈癌的预后,但其在宫颈癌发病机制中的精确功能和分子机制仍不清楚。在本研究中,通过在宫颈癌细胞系中过表达或沉默AurA,我们发现AurA的过表达通过G1/S细胞周期转换和抗凋亡促进细胞增殖、异种移植肿瘤生长以及对紫杉醇的化疗耐药。我们进一步发现,用其特异性抑制剂VX-680抑制AurA可通过诱导凋亡增强紫杉醇的抗肿瘤作用。此外,来自组织样本的临床分析表明,AurA在宫颈癌组织中过表达,且AurA与pERK1/2的表达在宫颈癌组织中呈负相关。上述结果可能为临床治疗宫颈癌提供一些潜在的见解。